Collaborations

Companies to develop cell lines for production of recombinant proteins

Published in Biotech Business Week, January 10th, 2005

Chromos Molecular Systems, Inc., (CHR) has entered into a collaborative agreement with Pfizer, Inc., to develop cell lines using the ACE (Artificial Chromosome Expression) System for production of Pfizer recombinant proteins.

Under the terms of the agreement, Chromos and Pfizer will collaborate to engineer a variety of cell lines specific for the expression of a Pfizer protein using the ACE System. Upon completion of the Pfizer-funded collaboration, Pfizer will evaluate the performance of the engineered cell lines. The financial details of the agreement were not disclosed.

"We are extremely pleased to be working with Pfizer, the world's largest...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2005-01-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry